Dianabol 20
Dianabol 20 Dragon Pharma — Overview
Dianabol 20 Dragon Pharma delivers Methandrostenolone at 20 mg per tablet — the classic oral anabolic that defined bulking cycles from the 1960s onward and remains one of the most widely used mass-building compounds in performance sport. At 20 mg per tablet, dosing is flexible: beginners can start at a single daily tablet, intermediate users typically run 2–2.5 tablets (40–50 mg/day), and the tab size avoids the rigid 50 mg increments that larger-dose formulations impose. Dianabol 20 is almost exclusively used as an oral kickstart — run for the first 4–6 weeks of a cycle while injectable compounds accumulate to effective steady-state levels.
Methandrostenolone is a 17-alpha alkylated testosterone derivative designed for oral bioavailability. The 17-AA modification protects the compound from first-pass liver metabolism, enabling meaningful plasma concentrations from an oral dose — but it is also responsible for the compound's hepatotoxic profile, which limits continuous use to 4–6 weeks. Within that window, Dianabol produces rapid and substantial increases in nitrogen retention, protein synthesis, glycogen storage, and androgenic anabolic drive — delivering strength and mass gains in the first 1–2 weeks of use that slower-acting injectables cannot match during their buildup phase. An injectable testosterone base must always be run alongside Dianabol.
About the Compound: Methandrostenolone
Methandrostenolone (also called methandienone) is a 17-alpha alkylated derivative of testosterone with a methyl group added at the C-1 position and a double bond introduced between C-1 and C-2. These modifications substantially increase oral bioavailability by protecting the molecule during hepatic first-pass metabolism, and they shift the compound's anabolic-to-androgenic ratio favorably relative to testosterone — with anabolic activity estimated at roughly 90–210% of testosterone and androgenic activity at approximately 40–60%. The practical result is a compound that produces strong anabolic stimulus in skeletal muscle with less androgenic burden than testosterone at equivalent anabolic doses, though the androgenic activity is still meaningful and produces characteristic androgen-related side effects in sensitive users.
The 17-AA modification also determines the compound's half-life and hepatic impact. With a plasma half-life of 3–6 hours, Methandrostenolone reaches peak concentrations 1–3 hours after ingestion and clears rapidly, requiring daily dosing to maintain consistent blood levels. Many users split the daily dose (morning and early afternoon) to smooth out the concentration curve; others take the full dose in a single sitting, typically with a meal to reduce gastrointestinal stress. Aromatization to 17-alpha methylestradiol is substantial — 17-alpha methylestradiol is more active per molar unit than regular estradiol due to its reduced binding to sex hormone binding globulin, which means estrogenic effects (water retention, breast tissue sensitivity) can emerge quickly even at moderate doses. AI co-administration from the first day of use is standard practice, not a reactive measure.
The hepatotoxic profile of Dianabol follows directly from the 17-AA modification: the alkyl group that enables oral activity also impairs hepatic processing of the molecule, causing elevated hepatic enzyme activity (AST, ALT) that normalizes after the compound is discontinued. This is the primary factor limiting Dianabol use to 4–6 weeks. Baseline and mid-run liver enzyme panels, liver support supplementation, and strict avoidance of other hepatotoxic substances (alcohol, acetaminophen, other 17-AA orals) during use are the standard management approach.
What Dianabol 20 Does
- Rapid mass and strength gains in weeks 1–2 — methandrostenolone produces measurable increases in bodyweight and training strength within the first two weeks of use — a rate of onset that no injectable compound can match; nitrogen retention improves rapidly, protein synthesis increases, and intramuscular glycogen storage expands, creating the characteristic "fullness" and increased training capacity that users report within days of starting; this makes Dianabol the standard kickstart compound for cycles built around slow-onset injectable esters (testosterone enanthate, testosterone cypionate, nandrolone decanoate) that require 3–4 weeks to reach effective steady state
- Nitrogen retention and positive protein balance — methandrostenolone produces a strongly positive nitrogen balance at performance doses; the body retains more nitrogen than it excretes, a direct measure of net anabolism; this effect begins within days of starting use and sustains lean mass accrual through the 4–6 week run; the glycogen supercompensation effect additionally increases muscle volumization and training output capacity independently of the protein synthesis component
- Synergistic anabolic effect when stacked with injectables — methandrostenolone and injectable testosterone act on androgen receptors through partially overlapping but non-identical mechanisms, with the oral compound's rapid receptor occupancy complementing the sustained receptor activation from testosterone; the combination produces greater total anabolic effect than either compound alone at equivalent individual doses; the first 4–6 weeks of a combined cycle (dbol + injectable) are typically the most rapid in terms of mass accumulation
- Strength increases beyond what mass gains alone account for — methandrostenolone's androgenic component increases central nervous system drive and motor unit recruitment alongside the anabolic effects; users consistently report that strength increases outpace the mass gained — lifting more weight within the first two weeks before muscle mass has grown proportionally; this neural component dissipates after the oral is discontinued but the mass gained from the full cycle is retained
- Flexible low-dose entry with 20 mg tablet sizing — the 20 mg tablet allows users to start at a conservative 20 mg/day (1 tablet) and titrate upward based on response and side effect tolerance; this is meaningfully more flexible than Dianabol 50 (50 mg tabs), which forces 50 mg increments and is impractical at the low end of the dosing range; users targeting 20–40 mg/day — the most evidence-supported dose range for mass gain with manageable side effects — find 20 mg tabs the most practical format
Who It's For
- Users starting their first anabolic cycle with an injectable base — Dianabol is one of the most well-characterized oral anabolic compounds, with documented outcomes going back to clinical research in the 1960s and 1970s; at 20–30 mg/day for 4 weeks alongside a testosterone base, it provides a clear, rapid anabolic signal that establishes what the compound does before the injectable builds; the 20 mg tab format allows starting at the low end of the dose range (1 tab/day) and increasing conservatively based on tolerance
- Intermediate users adding an oral kickstart to an injectable cycle — the 3–4 week buildup required for long-ester injectables (testosterone enanthate, testosterone cypionate, nandrolone decanoate) leaves a gap at the start of a cycle where anabolic output is below effective levels; Dianabol at 30–50 mg/day for weeks 1–4 fills this gap completely, delivering mass and strength while the injectable base accumulates; once the injectable reaches steady state, the oral is discontinued and the injectable carries the cycle
- Users who want oral dosing flexibility at the 20–40 mg range — the 20 mg tab is the practical format for users targeting this dose range; at 40 mg/day, two tablets deliver the dose exactly; at 30 mg/day, 1.5 tablets can be used; Dianabol 50 tabs would require splitting at these doses, introducing inconsistency; users who have experienced dose-dependent side effects at higher methandrostenolone doses and want to run a more controlled, lower-dose kickstart find Dianabol 20 the right format
- Classic mass cycles: test + optional nandrolone + dbol kickstart — the testosterone + Dianabol combination has the longest documented history of any injectable-oral stack in performance contexts; the three-compound stack (testosterone + nandrolone + Dianabol kickstart) is the most comprehensive mass-building protocol in common use; Dianabol 20 covers the kickstart component of either configuration with precise dosing control
Combinations
Dianabol 20 is an oral kickstart and requires an injectable testosterone base. The following Dragon Pharma additions address specific cycle configurations:
| Goal | Addition | Rationale |
|---|---|---|
| Injectable testosterone base (mandatory) | Cypionat 250 Dragon Pharma | Dianabol suppresses LH and FSH and must never be run without exogenous testosterone; testosterone cypionate at 400–500 mg/week provides the HPTA support and the sustained anabolic base that carries the cycle once the Dianabol kickstart ends at week 4–6; the long cypionate ester complements the oral's rapid action and takes over as the primary anabolic driver once it reaches steady state; exogenous testosterone also prevents the androgen deficit that causes libido suppression and mood deterioration in a Dianabol-only context |
| Classic mass stack: add nandrolone | Deca-300 Dragon Pharma | The test + deca + dbol combination is the most documented three-compound mass stack; Dianabol provides the oral kickstart during the first 4–6 weeks, testosterone cypionate provides the anabolic base, and Deca-300 adds joint support and additional anabolic stimulus through a distinct mechanism; the combination is appropriate for intermediate users who have run testosterone-only cycles and are ready to add a second injectable; both injectables continue for the full 12–16 weeks while the oral runs only the first 4–6 |
| Higher-dose methandrostenolone | Dianabol 50 Dragon Pharma | Users who have established their individual response to Dianabol at the 20–40 mg range and want to run 50–60 mg/day in subsequent cycles can step up to Dianabol 50 (50 mg/tab) for cleaner per-tablet dosing at higher ranges; at 50 mg/day, one Dianabol 50 tablet replaces 2.5 Dianabol 20 tablets; liver enzyme monitoring and hepatic support become more important as dose increases |
| Injectable methandrostenolone format | Dianabol Inj Dragon Pharma | For users who want to retain the methandrostenolone compound but reduce hepatic load, the injectable format delivers methandrostenolone intramuscularly, partially bypassing first-pass hepatic metabolism and reducing but not eliminating liver strain; injectable methandrostenolone has a longer effective half-life than the oral and is typically dosed less frequently; experienced users occasionally run both formats for distinct pharmacokinetic profiles within the same cycle |
| Leaner bulk: EQ-based stack | EQ 200 / Test E 200 Dragon Pharma | EQ 200 / Test E 200 combines boldenone undecylenate and testosterone enanthate in one vial for a leaner, more vascular mass-building base; using Dianabol 20 as an oral kickstart with this blend provides the rapid early-cycle anabolic effect while the equipoise and testosterone build; the combination produces leaner mass than a test-only or test + deca base due to equipoise's lower aromatization and distinct anabolic mechanism |
Side Effects & Management
Dianabol's side effect profile is driven by two mechanisms: estrogenic effects from its high aromatization rate, and direct hepatic stress from the 17-alpha alkylation. Both are manageable within a 4–6 week run with appropriate co-administration. Unlike nandrolone-based compounds, Dianabol's gynecomastia risk is estrogen-driven and responds fully to aromatase inhibitors — prolactin management is not required.
| What May Occur | Background | How to Handle It |
|---|---|---|
| Water retention and estrogenic bloat | Methandrostenolone aromatizes to 17-alpha methylestradiol, which has lower SHBG binding than regular estradiol and is therefore biologically more active per unit; estrogen-driven water retention is the most common and most rapid side effect of Dianabol use, often noticeable within the first week; significant water retention at higher doses (50+ mg/day) contributes to blood pressure elevation; the estrogen accumulation from both Dianabol and the concurrent testosterone base is additive | Aromasin Dragon Pharma at 12.5 mg EOD or Arimidex Dragon Pharma at 0.5 mg EOD from day one of the Dianabol run — not as a reactive measure once water retention develops; serum E2 blood work guides dose titration; avoid over-suppression (joint pain, mood impact) by using the minimum effective AI dose |
| Estrogenic gynecomastia | Elevated 17-alpha methylestradiol from Dianabol aromatization acts on breast tissue estrogen receptors; gyno from Dianabol responds to aromatase inhibitors — unlike nandrolone-related prolactin gyno, which does not; the Dianabol estrogen component stacks with any estrogen from the concurrent testosterone base, increasing the total estrogenic load the AI must manage; gyno symptoms (breast tissue sensitivity, puffiness behind the nipple) typically develop before visible tissue formation | AI co-administration from cycle day 1; Nolvadex Dragon Pharma at 20 mg/day as an add-on if nipple sensitivity develops despite AI use — SERMs block estrogen at breast tissue receptors directly and provide a second line of defence without further suppressing systemic estrogen |
| Liver enzyme elevation (hepatotoxicity) | The 17-alpha alkylation that makes Dianabol orally bioavailable also impairs hepatic processing of the molecule, causing elevated AST and ALT throughout the run; the degree of elevation correlates with dose and duration; elevations are expected and typically normalize 4–8 weeks after stopping; co-administration of other hepatotoxic agents (alcohol, acetaminophen, other 17-AA orals) during a Dianabol run is the primary risk factor for clinically significant liver stress rather than the compound alone | Liver enzyme panel (AST, ALT, bilirubin) at baseline and at 4 weeks; keep Dianabol runs to 6 weeks maximum; avoid all alcohol and over-the-counter hepatotoxic medications during the run; Liv.52 Herbal Liver Support throughout the cycle for ongoing hepatoprotective support; Mucinac (Acetylcysteine / NAC) at 600–1,200 mg/day as an antioxidant supporting hepatic glutathione levels |
| Blood pressure elevation | Two concurrent drivers: estrogen-driven water retention increases plasma volume and thus blood pressure; Dianabol's androgenic activity additionally increases hematocrit and red blood cell mass through EPO stimulation; the combined effect at doses above 30–40 mg/day alongside a testosterone base can produce meaningful blood pressure elevation, particularly in users with baseline elevated BP or those running 16-week cycles | Blood pressure monitoring at least weekly; aggressive AI management to reduce the estrogen-driven water component; restrict sodium intake; cardiovascular training throughout the cycle; if BP consistently exceeds 140/90 mmHg, dose reduction is the primary intervention — antihypertensives are a second line measure and do not address the underlying cause |
| Androgenic: acne, scalp, aggression | Methandrostenolone has an androgenic component (estimated ~40–60% of testosterone) and does convert to more androgenic metabolites at 5-alpha reductase, though to a lesser extent than testosterone; users with baseline sensitivity to androgens will experience acne (particularly on back and shoulders), accelerated scalp hair thinning, and elevated aggression; these effects are dose-dependent and more pronounced at doses above 40 mg/day | For acne: topical treatment first — benzoyl peroxide or adapalene; for persistent or cystic acne, Doxycycline at 100 mg/day or Isotroin (Isotretinoin) for severe cases; dose reduction is the primary lever for controlling androgenic side effects — switching to a lower-dose Dianabol run (20 mg/day) reduces androgenic burden substantially relative to 40–50 mg protocols |
| HPTA suppression and cholesterol | Dianabol suppresses LH and FSH rapidly; run without a testosterone base, libido, mood, and erectile function deteriorate within weeks; this is why a testosterone base is mandatory; oral AAS including Dianabol have a disproportionate negative impact on HDL cholesterol relative to injectables at comparable anabolic output — 4–6 weeks of Dianabol typically produces measurable HDL reduction that warrants monitoring | Injectable testosterone base mandatory throughout the Dianabol run and the full injectable cycle; lipid panel (HDL, LDL, triglycerides) at baseline and after the oral run; omega-3 supplementation (3–4 g/day EPA+DHA); for persistent post-cycle HDL suppression, Rosulip (Rosuvastatin) or Atorlip (Atorvastatin) |
PCT
Dianabol itself clears rapidly — its 3–6 hour half-life means it is essentially out of the system within 24–36 hours of the last tablet. PCT timing is therefore governed by the injectable compounds running alongside it, not by Dianabol itself. For a cycle built around long-ester injectables (testosterone cypionate or enanthate), PCT begins approximately 14 days after the last injectable injection. If nandrolone decanoate is also in the stack, the 21-day wait for nandrolone clearance takes precedence.
| Phase | Products | Protocol |
|---|---|---|
| On cycle — liver support | Liv.52 + Mucinac (NAC) | Liv.52 throughout the Dianabol run and for 4 weeks after; Mucinac (NAC) at 600–1,200 mg/day throughout; both are hepatoprotective rather than cycle support — do not wait for enzyme elevations to appear before starting |
| Wait before PCT (long-ester test base) | — | Approximately 14 days after the last testosterone enanthate or cypionate injection; Dianabol does not extend this window — its clearance is complete within 24–36 hours of the last tablet; if Deca-300 is in the stack, the window extends to 21 days (nandrolone decanoate clearance governs) |
| PCT weeks 1–2 | Clomid Dragon Pharma + Nolvadex Dragon Pharma | Clomid 50 mg/day + Nolvadex 40 mg/day; Clomid drives LH and FSH recovery at the hypothalamic and pituitary levels; Nolvadex provides complementary HPT stimulation and blocks any residual estrogen at breast tissue; combined SERM therapy is appropriate after a suppressive Dianabol + injectable cycle |
| PCT weeks 3–4 | Clomid Dragon Pharma + Nolvadex Dragon Pharma | Clomid 25 mg/day + Nolvadex 20 mg/day; taper as LH and FSH recover; confirm recovery with blood work (total testosterone, LH, FSH) at 4–6 weeks post-PCT; extend to 6 weeks if recovery is incomplete or if the total cycle ran 16+ weeks |
References
| Source | Topic | Link |
|---|---|---|
| PubMed / The Lancet | Methandienone and performance in men — controlled study of anabolic effects of methandienone in men undergoing athletic training; one of the earliest controlled investigations of methandrostenolone in a performance context | Hervey et al., 1976 ↗ |
| PubMed / British Medical Journal | Anabolic steroids in athletes — crossover double-blind trial on experienced male weightlifters examining methandienone effects in a strength-training context | Freed et al., 1975 ↗ |
| NCBI Bookshelf / StatPearls | Anabolic steroids overview — mechanism of action, pharmacological classification, anabolic-androgenic effects, common compounds including methandrostenolone class context, clinical use history, monitoring, and adverse effect profile | StatPearls: Anabolic Steroids ↗ |
| NCBI Bookshelf / LiverTox | Hepatotoxicity of androgenic anabolic steroids — C-17α alkylation, oral steroid liver injury, cholestasis, peliosis hepatis, hepatic adenomas, and management context | LiverTox: Androgenic Steroids ↗ |
| NCBI Bookshelf / Endotext | Androgen physiology and pharmacology — androgen receptor mechanism, testosterone biosynthesis, DHT conversion, estradiol aromatization, androgen therapy, and androgen misuse context | Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗ |
How to take Dianabol 20 mg?
Take 20-50 mg daily, split into 2-3 doses; see How to Use. Use with liver support and diet—consult professionals for tailored plans.
What does Dianabol 20 do?
It promotes rapid muscle and strength gains; see Mechanism of Action. It delivers a fuller physique—monitor with labs.
Is 20 mg of Dianabol enough?
20 mg is sufficient for beginners to see gains; see How to Use. Adjust based on experience—consult professionals for safety.
How long does Dianabol 20 stay in your system?
With a 4-6 hour half-life, it's detectable for 4-6 weeks; see Mechanism of Action. Plan PCT accordingly—consult professionals.
Is 20 mg of Dianabol safe?
20 mg is safe for beginners with monitoring; see Side Effects. Use liver support and ancillaries—consult professionals for safety.
How does Dianabol 20 mg work?
Dianabol 20 mg works by enhancing protein synthesis and nitrogen retention, creating an anabolic environment that supports muscle growth and recovery.
What are the main benefits of Dianabol 20 mg?
Commonly reported benefits include rapid muscle size increases, enhanced strength, improved training intensity, better recovery, and increased muscle fullness.
Is Dianabol 20 mg better for bulking or cutting?
Dianabol 20 mg is primarily associated with bulking and mass-gaining phases due to its ability to support significant increases in size and strength.
Related Products
